Sakai, Japan

Kiyomi Imano

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyomi Imano. Retrieved from https://idiyas.com/inventor/kiyomi-imano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyomi Imano: Innovator in Pharmaceutical Chemistry

Introduction

Kiyomi Imano is a notable inventor based in Sakai, Japan. She has made significant contributions to the field of pharmaceutical chemistry. Her work focuses on innovative compounds that have potential applications in medicine.

Latest Patents

Kiyomi Imano holds a patent for "2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same." This invention provides 2-furancarboxylic acid hydrazide compounds represented by General Formula (I). The compounds include prodrugs, physiologically acceptable salts, hydrates, and solvates. The formula features various groups and substitutions that enhance the compounds' therapeutic potential.

Career Highlights

Kiyomi Imano is associated with Dainippon Pharmaceutical Company, Limited. Her work at the company has been instrumental in advancing pharmaceutical research and development. She has a strong focus on creating innovative solutions for health-related challenges.

Collaborations

Kiyomi has collaborated with esteemed colleagues such as Akihito Fujii and Toshiyuki Negoro. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Kiyomi Imano's contributions to pharmaceutical chemistry exemplify her dedication to innovation. Her patent on 2-furancarboxylic acid hydrazides showcases her ability to develop valuable compounds for medical use. Through her work, she continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…